Healthcare Triangle, Inc.HCTI
Key ratios
FCF / Sales
-60.3%TTM
2025
-119.0%2024
-9.2%2023
-6.5%
Net margin
-66.3%TTM
2025
-68.2%2024
-51.0%2023
-26.2%
ROA
-20.9%TTM
2025
-49.6%2024
-67.3%2023
-37.2%
ROE
-57.4%TTM
2025
-392.4%2023
-373.7%
Revenue growth
116.4%TTM
2025
18.8%2024
-64.8%2023
-27.6%
Recent news
Healthcare Triangle Expands into Indonesia; Identifying USD 45 Million Opportunity
Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia
Three Months In, HCTI's Purpose Health Lands Multiple Wins as AI-Led Momentum Builds
Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan
HCTI Expands AI Business with 6 New Contracts, Targeting approx. $4.65M in Annual Run Rate Revenue
Healthcare Triangle, Inc Signs MOU to Bring AI-Enabled Humanoid Nursing Robots to Hospitals in North America
Healthcare Triangle Signs Letter of Intent to Pursue the Proposed Acquisition of Roboticom's Industrial Precision Robotics Automation Business
Healthcare Triangle (Nasdaq: HCTI) Joins Kanzun-ARCB Growth Fund to Build Malaysia-to-US Corridor for AI and Healthcare Companies
Healthcare Triangle to Distribute Minority Interest of Teyame AI Holdings Shares to HCTI Shareholders
Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026
Track HCTI in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer